Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.
Identifieur interne : 000065 ( Main/Curation ); précédent : 000064; suivant : 000066Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.
Auteurs : J. Marin-Corral [Espagne] ; C. Climent [Espagne] ; R. Mu Oz [Espagne] ; M. Samper [Espagne] ; I. Dot [Espagne] ; C. Vilà [Espagne] ; J R Masclans [Espagne] ; A. Rodriguez [Espagne] ; I. Martin-Loeches ; F. Álvarez-Lerma [Espagne]Source :
- Medicina intensiva [ 1578-6749 ] ; 2018.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Antiviraux (usage thérapeutique), Association thérapeutique (MeSH), Comorbidité (MeSH), Décubitus ventral (MeSH), Enregistrements (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (thérapie), Grippe humaine (traitement médicamenteux), Grippe humaine (virologie), Grippe humaine (épidémiologie), Guides de bonnes pratiques cliniques comme sujet (MeSH), Hormones corticosurrénaliennes (usage thérapeutique), Hospitalisation (statistiques et données numériques), Humains (MeSH), Indice de gravité de la maladie (MeSH), Infection croisée (épidémiologie), Infections bactériennes (épidémiologie), Mâle (MeSH), Retard de diagnostic (MeSH), Répartition par âge (MeSH), Sous-type H1N1 du virus de la grippe A (MeSH), Unités de soins intensifs (statistiques et données numériques), Utilisation des procédures et des techniques (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (MeSH), Vasoconstricteurs (usage thérapeutique), Ventilation artificielle (statistiques et données numériques), Épidémies de maladies (MeSH), Études prospectives (MeSH).
- MESH :
- statistiques et données numériques : Hospitalisation, Unités de soins intensifs, Vaccination, Ventilation artificielle.
- thérapie : Grippe humaine.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Hormones corticosurrénaliennes, Vasoconstricteurs.
- virologie : Grippe humaine.
- épidémiologie : Espagne, Grippe humaine, Infection croisée, Infections bactériennes.
- Adulte, Adulte d'âge moyen, Association thérapeutique, Comorbidité, Décubitus ventral, Enregistrements, Femelle, Guides de bonnes pratiques cliniques comme sujet, Humains, Indice de gravité de la maladie, Mâle, Retard de diagnostic, Répartition par âge, Sous-type H1N1 du virus de la grippe A, Utilisation des procédures et des techniques, Vaccins antigrippaux, Épidémies de maladies, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (therapeutic use), Adult (MeSH), Age Distribution (MeSH), Antiviral Agents (therapeutic use), Bacterial Infections (epidemiology), Combined Modality Therapy (MeSH), Comorbidity (MeSH), Cross Infection (epidemiology), Delayed Diagnosis (MeSH), Disease Outbreaks (MeSH), Female (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Influenza A Virus, H1N1 Subtype (MeSH), Influenza Vaccines (MeSH), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (therapy), Influenza, Human (virology), Intensive Care Units (statistics & numerical data), Male (MeSH), Middle Aged (MeSH), Practice Guidelines as Topic (MeSH), Procedures and Techniques Utilization (MeSH), Prone Position (MeSH), Prospective Studies (MeSH), Registries (MeSH), Respiration, Artificial (statistics & numerical data), Severity of Illness Index (MeSH), Spain (epidemiology), Vaccination (statistics & numerical data), Vasoconstrictor Agents (therapeutic use).
- MESH :
- chemical , therapeutic use : Adrenal Cortex Hormones, Antiviral Agents, Vasoconstrictor Agents.
- geographic , epidemiology : Spain.
- drug therapy : Influenza, Human.
- epidemiology : Bacterial Infections, Cross Infection, Influenza, Human.
- statistics & numerical data : Hospitalization, Intensive Care Units, Respiration, Artificial, Vaccination.
- therapy : Influenza, Human.
- virology : Influenza, Human.
- Adult, Age Distribution, Combined Modality Therapy, Comorbidity, Delayed Diagnosis, Disease Outbreaks, Female, Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines, Male, Middle Aged, Practice Guidelines as Topic, Procedures and Techniques Utilization, Prone Position, Prospective Studies, Registries, Severity of Illness Index.
Abstract
OBJECTIVES
To evaluate the impact of the recommendations of the SEMICYUC (2012) on severe influenza A.
DESIGN
A prospective multicenter observational study was carried out.
SETTING
ICU.
PATIENTS
Patients infected with severe influenza A (H1N1) from the GETGAG/SEMICYUC registry.
INTERVENTIONS
Analysis of 2 groups according to the epidemic period of the diagnosis (2009-2011; 2013-2015).
VARIABLES
Demographic, temporal, comorbidities, severity, treatments, mortality, late diagnosis and place of acquisition.
RESULTS
A total of 2,205 patients were included, 1,337 (60.6%) in the first period and 868 (39.4%) in the second one. Age and severity on admission were significantly greater in the second period, as well as co-infection. With regard to the impact of the recommendations, in the second period the diagnosis was established earlier (70.8 vs. 61.1%, P<.001), without changes in the start of treatment. Patients received less corticosteroid treatment (39.7 vs. 44.9%, P<.05), more NIMV was used (47.4 vs. 33.2%, P<.001) and more vaccination was made (11.1 vs. 1.7%, P<.001), without changes in mortality (24.2 vs. 20.7%). A decrease in nosocomial infection was also noted (9.8 vs. 16%, P<.001). Patients needed less MV with more days of ventilation, more vasopressor drug use and more ventral decubitus.
CONCLUSIONS
The management of patients with severe influenza A (H1N1) has changed over the years, though without changes in mortality. The recommendations of the SEMICYUC (2012) have allowed earlier diagnosis and improved corticosteroid use. Pending challenges are the delay in treatment, the vaccination rate and the use of NIMV.
DOI: 10.1016/j.medin.2018.02.002
PubMed: 29559173
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :00065
Links to Exploration step
pubmed:29559173Curation
No country items
I. Martin-Loeches<affiliation><nlm:affiliation>Service of Intensive Care Medicine, St. James's Hospital, Dublin, Irlanda.</nlm:affiliation>
<wicri:noCountry code="subField">Irlanda</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.</title>
<author><name sortKey="Marin Corral, J" sort="Marin Corral, J" uniqKey="Marin Corral J" first="J" last="Marin-Corral">J. Marin-Corral</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España. Electronic address: jmarincorral@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Climent, C" sort="Climent, C" uniqKey="Climent C" first="C" last="Climent">C. Climent</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mu Oz, R" sort="Mu Oz, R" uniqKey="Mu Oz R" first="R" last="Mu Oz">R. Mu Oz</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Samper, M" sort="Samper, M" uniqKey="Samper M" first="M" last="Samper">M. Samper</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dot, I" sort="Dot, I" uniqKey="Dot I" first="I" last="Dot">I. Dot</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vila, C" sort="Vila, C" uniqKey="Vila C" first="C" last="Vilà">C. Vilà</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Masclans, J R" sort="Masclans, J R" uniqKey="Masclans J" first="J R" last="Masclans">J R Masclans</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rodriguez, A" sort="Rodriguez, A" uniqKey="Rodriguez A" first="A" last="Rodriguez">A. Rodriguez</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España; Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Institut d'Investigació Sanitària Pere Virgili (IISPV)-Universitat Rovira i Virgili (URV), Tarragona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España; Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Institut d'Investigació Sanitària Pere Virgili (IISPV)-Universitat Rovira i Virgili (URV), Tarragona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Martin Loeches, I" sort="Martin Loeches, I" uniqKey="Martin Loeches I" first="I" last="Martin-Loeches">I. Martin-Loeches</name>
<affiliation><nlm:affiliation>Service of Intensive Care Medicine, St. James's Hospital, Dublin, Irlanda.</nlm:affiliation>
<wicri:noCountry code="subField">Irlanda</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Alvarez Lerma, F" sort="Alvarez Lerma, F" uniqKey="Alvarez Lerma F" first="F" last="Álvarez-Lerma">F. Álvarez-Lerma</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29559173</idno>
<idno type="pmid">29559173</idno>
<idno type="doi">10.1016/j.medin.2018.02.002</idno>
<idno type="wicri:Area/Main/Corpus">00065</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00065</idno>
<idno type="wicri:Area/Main/Curation">000065</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000065</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.</title>
<author><name sortKey="Marin Corral, J" sort="Marin Corral, J" uniqKey="Marin Corral J" first="J" last="Marin-Corral">J. Marin-Corral</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España. Electronic address: jmarincorral@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Climent, C" sort="Climent, C" uniqKey="Climent C" first="C" last="Climent">C. Climent</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mu Oz, R" sort="Mu Oz, R" uniqKey="Mu Oz R" first="R" last="Mu Oz">R. Mu Oz</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Samper, M" sort="Samper, M" uniqKey="Samper M" first="M" last="Samper">M. Samper</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dot, I" sort="Dot, I" uniqKey="Dot I" first="I" last="Dot">I. Dot</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vila, C" sort="Vila, C" uniqKey="Vila C" first="C" last="Vilà">C. Vilà</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Masclans, J R" sort="Masclans, J R" uniqKey="Masclans J" first="J R" last="Masclans">J R Masclans</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rodriguez, A" sort="Rodriguez, A" uniqKey="Rodriguez A" first="A" last="Rodriguez">A. Rodriguez</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España; Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Institut d'Investigació Sanitària Pere Virgili (IISPV)-Universitat Rovira i Virgili (URV), Tarragona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España; Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Institut d'Investigació Sanitària Pere Virgili (IISPV)-Universitat Rovira i Virgili (URV), Tarragona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Martin Loeches, I" sort="Martin Loeches, I" uniqKey="Martin Loeches I" first="I" last="Martin-Loeches">I. Martin-Loeches</name>
<affiliation><nlm:affiliation>Service of Intensive Care Medicine, St. James's Hospital, Dublin, Irlanda.</nlm:affiliation>
<wicri:noCountry code="subField">Irlanda</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Alvarez Lerma, F" sort="Alvarez Lerma, F" uniqKey="Alvarez Lerma F" first="F" last="Álvarez-Lerma">F. Álvarez-Lerma</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Medicina intensiva</title>
<idno type="eISSN">1578-6749</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (therapeutic use)</term>
<term>Adult (MeSH)</term>
<term>Age Distribution (MeSH)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Bacterial Infections (epidemiology)</term>
<term>Combined Modality Therapy (MeSH)</term>
<term>Comorbidity (MeSH)</term>
<term>Cross Infection (epidemiology)</term>
<term>Delayed Diagnosis (MeSH)</term>
<term>Disease Outbreaks (MeSH)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (statistics & numerical data)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (MeSH)</term>
<term>Influenza Vaccines (MeSH)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (therapy)</term>
<term>Influenza, Human (virology)</term>
<term>Intensive Care Units (statistics & numerical data)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Practice Guidelines as Topic (MeSH)</term>
<term>Procedures and Techniques Utilization (MeSH)</term>
<term>Prone Position (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Registries (MeSH)</term>
<term>Respiration, Artificial (statistics & numerical data)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Vaccination (statistics & numerical data)</term>
<term>Vasoconstrictor Agents (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Association thérapeutique (MeSH)</term>
<term>Comorbidité (MeSH)</term>
<term>Décubitus ventral (MeSH)</term>
<term>Enregistrements (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (thérapie)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term>
<term>Hormones corticosurrénaliennes (usage thérapeutique)</term>
<term>Hospitalisation (statistiques et données numériques)</term>
<term>Humains (MeSH)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infection croisée (épidémiologie)</term>
<term>Infections bactériennes (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Retard de diagnostic (MeSH)</term>
<term>Répartition par âge (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (MeSH)</term>
<term>Unités de soins intensifs (statistiques et données numériques)</term>
<term>Utilisation des procédures et des techniques (MeSH)</term>
<term>Vaccination (statistiques et données numériques)</term>
<term>Vaccins antigrippaux (MeSH)</term>
<term>Vasoconstricteurs (usage thérapeutique)</term>
<term>Ventilation artificielle (statistiques et données numériques)</term>
<term>Épidémies de maladies (MeSH)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term>
<term>Antiviral Agents</term>
<term>Vasoconstrictor Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Bacterial Infections</term>
<term>Cross Infection</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term>
<term>Intensive Care Units</term>
<term>Respiration, Artificial</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term>
<term>Unités de soins intensifs</term>
<term>Vaccination</term>
<term>Ventilation artificielle</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Hormones corticosurrénaliennes</term>
<term>Vasoconstricteurs</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Grippe humaine</term>
<term>Infection croisée</term>
<term>Infections bactériennes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Distribution</term>
<term>Combined Modality Therapy</term>
<term>Comorbidity</term>
<term>Delayed Diagnosis</term>
<term>Disease Outbreaks</term>
<term>Female</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza Vaccines</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Practice Guidelines as Topic</term>
<term>Procedures and Techniques Utilization</term>
<term>Prone Position</term>
<term>Prospective Studies</term>
<term>Registries</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Comorbidité</term>
<term>Décubitus ventral</term>
<term>Enregistrements</term>
<term>Femelle</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Retard de diagnostic</term>
<term>Répartition par âge</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Utilisation des procédures et des techniques</term>
<term>Vaccins antigrippaux</term>
<term>Épidémies de maladies</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b>
</p>
<p>To evaluate the impact of the recommendations of the SEMICYUC (2012) on severe influenza A.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>DESIGN</b>
</p>
<p>A prospective multicenter observational study was carried out.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>SETTING</b>
</p>
<p>ICU.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>PATIENTS</b>
</p>
<p>Patients infected with severe influenza A (H1N1) from the GETGAG/SEMICYUC registry.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>INTERVENTIONS</b>
</p>
<p>Analysis of 2 groups according to the epidemic period of the diagnosis (2009-2011; 2013-2015).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>VARIABLES</b>
</p>
<p>Demographic, temporal, comorbidities, severity, treatments, mortality, late diagnosis and place of acquisition.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>A total of 2,205 patients were included, 1,337 (60.6%) in the first period and 868 (39.4%) in the second one. Age and severity on admission were significantly greater in the second period, as well as co-infection. With regard to the impact of the recommendations, in the second period the diagnosis was established earlier (70.8 vs. 61.1%, P<.001), without changes in the start of treatment. Patients received less corticosteroid treatment (39.7 vs. 44.9%, P<.05), more NIMV was used (47.4 vs. 33.2%, P<.001) and more vaccination was made (11.1 vs. 1.7%, P<.001), without changes in mortality (24.2 vs. 20.7%). A decrease in nosocomial infection was also noted (9.8 vs. 16%, P<.001). Patients needed less MV with more days of ventilation, more vasopressor drug use and more ventral decubitus.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>The management of patients with severe influenza A (H1N1) has changed over the years, though without changes in mortality. The recommendations of the SEMICYUC (2012) have allowed earlier diagnosis and improved corticosteroid use. Pending challenges are the delay in treatment, the vaccination rate and the use of NIMV.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29559173</PMID>
<DateCompleted><Year>2019</Year>
<Month>06</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>06</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-6749</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>42</Volume>
<Issue>8</Issue>
<PubDate><Year>2018</Year>
<Month>11</Month>
</PubDate>
</JournalIssue>
<Title>Medicina intensiva</Title>
<ISOAbbreviation>Med Intensiva</ISOAbbreviation>
</Journal>
<ArticleTitle>Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.</ArticleTitle>
<Pagination><MedlinePgn>473-481</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0210-5691(18)30048-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2018.02.002</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES">To evaluate the impact of the recommendations of the SEMICYUC (2012) on severe influenza A.</AbstractText>
<AbstractText Label="DESIGN">A prospective multicenter observational study was carried out.</AbstractText>
<AbstractText Label="SETTING">ICU.</AbstractText>
<AbstractText Label="PATIENTS">Patients infected with severe influenza A (H1N1) from the GETGAG/SEMICYUC registry.</AbstractText>
<AbstractText Label="INTERVENTIONS">Analysis of 2 groups according to the epidemic period of the diagnosis (2009-2011; 2013-2015).</AbstractText>
<AbstractText Label="VARIABLES">Demographic, temporal, comorbidities, severity, treatments, mortality, late diagnosis and place of acquisition.</AbstractText>
<AbstractText Label="RESULTS">A total of 2,205 patients were included, 1,337 (60.6%) in the first period and 868 (39.4%) in the second one. Age and severity on admission were significantly greater in the second period, as well as co-infection. With regard to the impact of the recommendations, in the second period the diagnosis was established earlier (70.8 vs. 61.1%, P<.001), without changes in the start of treatment. Patients received less corticosteroid treatment (39.7 vs. 44.9%, P<.05), more NIMV was used (47.4 vs. 33.2%, P<.001) and more vaccination was made (11.1 vs. 1.7%, P<.001), without changes in mortality (24.2 vs. 20.7%). A decrease in nosocomial infection was also noted (9.8 vs. 16%, P<.001). Patients needed less MV with more days of ventilation, more vasopressor drug use and more ventral decubitus.</AbstractText>
<AbstractText Label="CONCLUSIONS">The management of patients with severe influenza A (H1N1) has changed over the years, though without changes in mortality. The recommendations of the SEMICYUC (2012) have allowed earlier diagnosis and improved corticosteroid use. Pending challenges are the delay in treatment, the vaccination rate and the use of NIMV.</AbstractText>
<CopyrightInformation>Copyright © 2018 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marin-Corral</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España. Electronic address: jmarincorral@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Climent</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Muñoz</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Samper</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dot</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vilà</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Masclans</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rodriguez</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España; Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Institut d'Investigació Sanitària Pere Virgili (IISPV)-Universitat Rovira i Virgili (URV), Tarragona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Martin-Loeches</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Service of Intensive Care Medicine, St. James's Hospital, Dublin, Irlanda.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Álvarez-Lerma</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España; Grupo de Investigación en Patología Crítica (GREPAC), Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>en representacion del Grupo de Trabajo H1N1 GETGAG SEMICYUC</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<Language>spa</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
</PublicationTypeList>
<VernacularTitle>Pacientes con gripe por el virus influenza A (H1N1)pdm09 ingresados en la UCI. Impacto de las recomendaciones de la SEMICYUC.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>03</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Med Intensiva</MedlineTA>
<NlmUniqueID>9207689</NlmUniqueID>
<ISSNLinking>0210-5691</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Med Intensiva. 2019 Dec;43(9):584-585</RefSource>
<PMID Version="1">30522872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Med Intensiva. 2019 Dec;43(9):585-586</RefSource>
<PMID Version="1">30661839</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057210" MajorTopicYN="N">Delayed Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000078337" MajorTopicYN="N">Procedures and Techniques Utilization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016684" MajorTopicYN="N">Prone Position</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Critically illness</Keyword>
<Keyword MajorTopicYN="Y">Enfermedad crítica</Keyword>
<Keyword MajorTopicYN="Y">Infección por virus influenza A (H1N1)pdm09</Keyword>
<Keyword MajorTopicYN="Y">Influenza A (H1N1)pdm09 virus infection</Keyword>
<Keyword MajorTopicYN="Y">Intensive Care Unit</Keyword>
<Keyword MajorTopicYN="Y">Manejo terapéutico</Keyword>
<Keyword MajorTopicYN="Y">Mortalidad</Keyword>
<Keyword MajorTopicYN="Y">Mortality</Keyword>
<Keyword MajorTopicYN="Y">Outcome</Keyword>
<Keyword MajorTopicYN="Y">Pronóstico</Keyword>
<Keyword MajorTopicYN="Y">Therapeutic management</Keyword>
<Keyword MajorTopicYN="Y">Unidad de Cuidados Intensivos</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>10</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2018</Year>
<Month>01</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>02</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29559173</ArticleId>
<ArticleId IdType="pii">S0210-5691(18)30048-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.medin.2018.02.002</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000065 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000065 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeEspagneV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:29559173 |texte= Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:29559173" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a GrippeEspagneV1
This area was generated with Dilib version V0.6.37. |